Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon in well-trained cyclists
NL-OMON44014Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Mar 2016
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing NeoRecormon with Placebo (2 arms). Primary endpoints: Exercise test respiratory gas parameters, Exercise test blood biomarkers and 4 more. Started Mar 2016; status: active, not recruiting.
02
Drugs
epoetin beta
Beyond the preview
Go deeper on NL-OMON44014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44014.